U.S. Accelerates Shift Away From Animal Testing as AI and Human-Based Models Reshape Drug Research 

The U.S. Department of Health and Human Services is accelerating a major transformation in biomedical research, launching new initiatives intended to reduce reliance on animal testing while expanding the use of human cells, organoids, organs-on-chips, artificial intelligence and computational models in drug development. The effort represents one of the federal...